This study is looking at two FDA-approved medications, romosozumab and teriparatide, to see how well they treat osteoporosis (a condition that makes bones weak and more likely to break) in women after menopause. You may be able to join if you are a woman aged 45 or older, have gone through menopause, and have osteoporosis with a high risk of fractures. We are trying to see if these treatments improve your bone mineral density in your lower back over 12 months. The current recruitment status is unclear.

Study design

This interventional study plans to enroll 50 participants. It is testing two different drug regimens.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your bone mineral density will be measured from the start of the study up to 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.